Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell-free DNA: Comparison of Technologies.

Clinics in laboratory medicine - 1 Jun 2016

Dar Pe'er, Shani Hagit, Evans Mark I

Abstract excerpt

Cell-free fetal DNA screening for Down syndrome has gained rapid acceptance over the past few years with increasing market penetration. Three main laboratory methodologies are currently used: a massive parallel shotgun sequencing (MPSS), a targeted massive parallel sequencing (t-MPS) and a single nucleotide polymorphism (SNP) based approach. Although each of these technologies has its own advantages and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aneuploidy
Share to DNA
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Genetic Testing

Share to High-Throughput Nucleotide Sequencing

Share to Prenatal Diagnosis

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 27235906
DOI: 10.1016/j.cll.2016.01.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell-free DNA: Comparison of Technologies.PMID 27235906Read ↗

Noninvasive prenatal diagnosis empowered by high‐throughput sequencingSemantic proximity Read ↗

Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screeningSemantic proximity Read ↗

International Society for Prenatal Diagnosis Position Statement: cell free (cf) DNA screening for Down syndrome in multiple pregnanciesSemantic proximity Read ↗

Cell-free DNA for the detection of fetal aneuploidy.Semantic proximity Read ↗

Clinical Perspective of Cell-Free DNA Testing for Fetal AneuploidiesSemantic proximity Read ↗

Current controversies in prenatal diagnosis 2: Cell‐free DNA prenatal screening should be used to identify all chromosome abnormalitiesSemantic proximity Read ↗

Current Status of Testing for Microdeletion Syndromes and Rare Autosomal Trisomies Using Cell-Free DNA TechnologySemantic proximity Read ↗

A robust second‐generation genome‐wide test for fetal aneuploidy based on shotgun sequencing cell‐free DNA in maternal bloodSemantic proximity Read ↗

Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.Semantic proximity Read ↗

Noninvasive prenatal testing for aneuploidy using cell-free DNA – New implications for maternal healthSemantic proximity Read ↗

Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal bloodSemantic proximity Read ↗

Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.